Presentation overview

• From LYMErix...

  • Rationale for OspA-based vaccine
  • Mechanism of protection
  • LYMErix

• … to a European vaccine

  • Borrelia in Europe
  • Lyme Europe vaccine composition
  • preclinical data
  • clinical data

Previous slide

Next slide

Back to first slide

View graphic version